210 related articles for article (PubMed ID: 11432687)
1. Effects of central noradrenaline depletion by the selective neurotoxin DSP-4 on the behaviour of the isolated rat in the elevated plus maze and water maze.
Lapiz MD; Mateo Y; Durkin S; Parker T; Marsden CA
Psychopharmacology (Berl); 2001 May; 155(3):251-9. PubMed ID: 11432687
[TBL] [Abstract][Full Text] [Related]
2. Effects of noradrenaline depletion in the brain on response on novelty in isolation-reared rats.
Lapiz MD; Mateo Y; Parker T; Marsden C
Psychopharmacology (Berl); 2000 Oct; 152(3):312-20. PubMed ID: 11105942
[TBL] [Abstract][Full Text] [Related]
3. Selective brain noradrenaline depletion induced by the neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP 4) does not prevent the memory facilitation induced by a muscarinic agonist in mice.
Introini IB; Baratti CM; Huygens P
Psychopharmacology (Berl); 1984; 82(1-2):107-12. PubMed ID: 6420819
[TBL] [Abstract][Full Text] [Related]
4. Overflow of noradrenaline and dopamine in frontal cortex after [N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine] (DSP-4) treatment: in vivo microdialysis study in anaesthetized rats.
Kask A; Harro J; Tuomaine P; Rägo L; Männistö PT
Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):267-72. PubMed ID: 9050022
[TBL] [Abstract][Full Text] [Related]
5. The effects of noradrenergic neurotoxin, DSP-4, on the performance of young and aged rats in spatial navigation task.
Sirviö J; Riekkinen P; Valjakka A; Jolkkonen J; Riekkinen PJ
Brain Res; 1991 Nov; 563(1-2):297-302. PubMed ID: 1786544
[TBL] [Abstract][Full Text] [Related]
6. Selective effects of DSP-4 on locus coeruleus axons: are there pharmacologically different types of noradrenergic axons in the central nervous system?
Fritschy JM; Grzanna R
Prog Brain Res; 1991; 88():257-68. PubMed ID: 1726027
[TBL] [Abstract][Full Text] [Related]
7. A partial noradrenergic lesion induced by DSP-4 increases extracellular noradrenaline concentration in rat frontal cortex: a microdialysis study in vivo.
Hughes ZA; Stanford SC
Psychopharmacology (Berl); 1998 Apr; 136(3):299-303. PubMed ID: 9566816
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of MAO B, but not MAO A, blocks DSP-4 toxicity on central NE neurons.
Gibson CJ
Eur J Pharmacol; 1987 Sep; 141(1):135-8. PubMed ID: 3117577
[TBL] [Abstract][Full Text] [Related]
9. Effect of DSP-4 induced central noradrenergic depletion on tactile learning in rat.
Rajabi S; Shamsizadeh A; Amini H; Shirazi M; Allahtavakoli M; Abbasnejad M; Sheibani V
Neurol Res; 2012 Jan; 34(1):80-4. PubMed ID: 22196866
[TBL] [Abstract][Full Text] [Related]
10. Pretraining infusion of DSP-4 into the amygdala impaired retention in the inhibitory avoidance task: involvement of norepinephrine but not serotonin in memory facilitation.
Liang KC
Chin J Physiol; 1998 Dec; 41(4):223-33. PubMed ID: 10099870
[TBL] [Abstract][Full Text] [Related]
11. The effect of central cholinergic and noradrenergic denervation on hippocampal sympathetic ingrowth and apoptosis-like reactivity in the rat.
Harrell LE; Parsons DS; Kolasa K
Brain Res; 2005 Feb; 1033(1):68-77. PubMed ID: 15680341
[TBL] [Abstract][Full Text] [Related]
12. Noradrenergic DSP-4 lesions aggravate impairment of working memory produced by hippocampal muscarinic blockade in rats.
Ohno M; Yoshimatsu A; Kobayashi M; Watanabe S
Pharmacol Biochem Behav; 1997; 57(1-2):257-61. PubMed ID: 9164580
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals.
Fritschy JM; Grzanna R
Neuroscience; 1989; 30(1):181-97. PubMed ID: 2747911
[TBL] [Abstract][Full Text] [Related]
14. Quantification of presynaptic alpha 2-adrenoceptors in rat brain after short-term DSP-4 lesioning.
Heal DJ; Butler SA; Prow MR; Buckett WR
Eur J Pharmacol; 1993 Nov; 249(1):37-41. PubMed ID: 7506666
[TBL] [Abstract][Full Text] [Related]
15. Effects of vagus nerve stimulation on cognitive functioning in rats with cerebral ischemia reperfusion.
Liu AF; Zhao FB; Wang J; Lu YF; Tian J; Zhao Y; Gao Y; Hu XJ; Liu XY; Tan J; Tian YL; Shi J
J Transl Med; 2016 Apr; 14():101. PubMed ID: 27118204
[TBL] [Abstract][Full Text] [Related]
16. Effects of single and simultaneous lesions of serotonergic and noradrenergic pathways on open-space and bright-space anxiety-like behavior in two animal models.
Sziray N; Kuki Z; Nagy KM; Markó B; Kompagne H; Lévay G
Behav Brain Res; 2010 May; 209(1):93-8. PubMed ID: 20096733
[TBL] [Abstract][Full Text] [Related]
17. Modulation of behaviour on trials 1 and 2 in the elevated plus-maze test of anxiety after systemic and hippocampal administration of nicotine.
Ouagazzal AM; Kenny PJ; File SE
Psychopharmacology (Berl); 1999 May; 144(1):54-60. PubMed ID: 10379624
[TBL] [Abstract][Full Text] [Related]
18. Changes in cholecystokinin receptor binding in rat brain after selective damage of locus coeruleus projections by DSP-4 treatment.
Harro J; Jossan SS; Oreland L
Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):425-31. PubMed ID: 1436127
[TBL] [Abstract][Full Text] [Related]
19. Neonatal DSP-4 treatment impairs 5-HT(1B) receptor reactivity in adult rats. Behavioral and biochemical studies.
Ferdyn-Drosik M; Nowak P; Bojanek K; Bałasz M; Kasperski J; Skaba D; Muchacki R; Kostrzewa RM
Pharmacol Rep; 2010; 62(4):608-20. PubMed ID: 20885001
[TBL] [Abstract][Full Text] [Related]
20. Neurotoxic effects of DSP-4 on the central noradrenergic system in male zebra finches.
Waterman SA; Harding CF
Behav Brain Res; 2008 Apr; 188(2):271-80. PubMed ID: 18160108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
